Simone Lucarini Selected Research

Parkinson Disease (Parkinson's Disease)

7/2015	Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A2A Receptor Ligands.
7/2013	Synthesis and biological evaluation of metabolites of 2-n-butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), a potent antagonist of the A2A adenosine receptor for the treatment of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simone Lucarini Research Topics

Disease

3	Neoplasms (Cancer) 07/2022 - 05/2013
3	Breast Neoplasms (Breast Cancer) 01/2015 - 03/2011
2	Infections 12/2021 - 08/2020
2	Parkinson Disease (Parkinson's Disease) 07/2015 - 07/2013
1	Wounds and Injuries (Trauma) 03/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2015
1	Triple Negative Breast Neoplasms 03/2011
1	Autolysis 03/2011

Drug/Important Bio-Agent (IBA)

3	indole-3-carbinolIBA 01/2015 - 03/2011
2	AlkaloidsIBA 07/2022 - 04/2018
2	Biological ProductsIBA 03/2022 - 07/2013
2	Hormones (Hormone)IBA 05/2013 - 03/2011
1	BromineIBA 07/2022
1	SugarsIBA 03/2022
1	Sucrose (Saccharose)IBA 03/2022
1	Biocompatible Materials (Biomaterials)IBA 03/2022
1	Linoleic Acid (Linoleate)IBA 03/2022
1	alpha-Linolenic Acid (Linolenic Acid)IBA 03/2022
1	sucrose monolaurateIBA 03/2022
1	EstersIBA 03/2022
1	Lactose FDA LinkGeneric 03/2022
1	ChitosanIBA 03/2022
1	AntioxidantsIBA 03/2022
1	Pharmaceutical PreparationsIBA 12/2021
1	Pentamidine (NebuPent)FDA LinkGeneric 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2020
1	2,2-bis(6-bromo-3-indolyl) ethylamineIBA 04/2018
1	ramelteon (Rozerem)FDA Link 07/2015
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 07/2015
1	Aromatase (CYP19)IBA 01/2015
1	Testosterone (Sustanon)FDA Link 01/2015
1	Aromatase InhibitorsIBA 01/2015
1	2- n- butyl- 9- methyl- 8- (1,2,3)triazol- 2- yl- 9H- purin- 6- ylamineIBA 07/2013
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 07/2013
1	Cyclin EIBA 05/2013
1	GlucosinolatesIBA 03/2011
1	CyclodextrinsIBA 03/2011
1	Proteins (Proteins, Gene)FDA Link 03/2011
1	Estrogen ReceptorsIBA 03/2011
1	Propidium (Propidium Iodide)IBA 03/2011
1	Antineoplastic Agents (Antineoplastics)IBA 03/2011

Therapy/Procedure

2	Therapeutics 07/2022 - 07/2015
1	Chemoprevention 01/2015
1	Injections 03/2011